Literature DB >> 3543502

Studies on the mechanisms of action of progesterone antagonists.

W Elger, S Beier, K Chwalisz, M Fähnrich, S H Hasan, D Henderson, G Neef, R Rohde.   

Abstract

Antigestagens of RU-38.486-type were investigated in different pregnancy models reflecting either "endometrial" or "myometrial" effects. All antigestagens were found effective inhibitors of nidation in guinea pigs. This was evidence for a role of embryonic progesterone in the earliest events of nidation. No comparable inhibition could be obtained by ovariectomy. A more complex pharmacology was found around day 43 p.c. when the abortion was brought about by expulsion. RU-38.486 had marginal activity only. Antigestagens with reduced anti-glucocorticoid activity tended to induce abortions more effectively and faster. Some antigestagen-prostaglandin combinations were found of extreme abortifacient activity. Surprisingly it seemed that anti-glucocorticoid properties in addition to (or rather than) antigestagenic activities bring about this synergism with prostaglandin. The employed guinea pig model for pregnancy termination thus characterized two types of antigestagens: ideal ones for monotherapy or combined use with prostaglandin, respectively. Antigestagens induced a highly sensitive myometrium to prostaglandin-stimulation (Sulprostone) and a marked softening and dilatation of the cervix. Antigestagens perfectly prime the genital tract for oxytocic stimuli, they do not overcome the arrested uterine prostaglandin-secretion of the pregnant uterus at the same time.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3543502     DOI: 10.1016/0022-4731(86)90314-6

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  8 in total

1.  Changes in rat myometrial plasma membrane protein kinase A are confined to parturition.

Authors:  Chun-Ying Ku; Dilyara A Murtazina; Yoon-Sun Kim; Robert E Garfield; Barbara M Sanborn
Journal:  Reprod Sci       Date:  2010-05-10       Impact factor: 3.060

2.  Two types of antiprogestins identified by their differential action in transcriptionally active extracts from T47D cells.

Authors:  L Klein-Hitpass; A C Cato; D Henderson; G U Ryffel
Journal:  Nucleic Acids Res       Date:  1991-03-25       Impact factor: 16.971

3.  [Morphologic aspects of cervix ripening produced by progestin antagonists].

Authors:  C Hegele-Hartung; K Chwalisz; H M Beier; W Elger
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

4.  A study of the effect of mifepristone (antiprogesterone) followed by prostaglandin on uterine activity and fetal heart rate in patients having a termination of pregnancy.

Authors:  M O Pulkkinen; O Piiroinen; J Vainikka
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

5.  Prostaglandin H2 synthase-1 and -2 expression in guinea pig gestational tissues during late pregnancy and parturition.

Authors:  Toni Welsh; Carolyn M Mitchell; William A Walters; Sam Mesiano; Tamas Zakar
Journal:  J Physiol       Date:  2005-10-20       Impact factor: 5.182

6.  Antitumor activity of the antiprogestins ZK 98.299 and RU 38.486 in hormone dependent rat and mouse mammary tumors: mechanistic studies.

Authors:  H Michna; M R Schneider; Y Nishino; M F el Etreby
Journal:  Breast Cancer Res Treat       Date:  1989-12       Impact factor: 4.872

Review 7.  Steroid receptor domain conformations and hormone antagonism.

Authors:  M K Agarwal
Journal:  Naturwissenschaften       Date:  1994-03

Review 8.  Progesterone action in the myometrium and decidua in preterm birth.

Authors:  A M Blanks; J J Brosens
Journal:  Facts Views Vis Obgyn       Date:  2012
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.